Heart Failure Clinical Trial
Helping Others Toward Positive Emotions in People With Heart Failure
Summary
Heart failure (HF) affects 5 million people in the US and is the most common cause of hospitalization in elderly adults. One-third of patients who are hospitalized with HF have major depression. Depressed HF patients have double the rates of morbidity and/or mortality and worse health-related quality of life than non-depressed HF patients. The investigators previous pilot research suggests that a brief Cognitive Therapy (CT) intervention may improve short-term cardiac survival among depressed hospitalized HF patients compared to non-depressed HF patients who received usual care. Therefore, the investigators will conduct a larger study to evaluate the effects of the intervention on longer cardiac event-free survival, symptoms of depression, health-related quality of life, and stress levels in patients with HF. The investigators hypothesize that patients in the intervention group will experience longer cardiac event-free survival, lower levels of depressive symptom, better health-related quality of life, and lower salivary cortisol levels at follow-up than patients who receive usual care.
Eligibility Criteria
Inclusion Criteria:
Admitted to the hospital with a primary or secondary diagnosis of congestive heart failure OR admitted to the hospital for cardiac reasons and has a history of chronic heart failure
American College of Cardiology/ American Heart Association Stage C HF
21 years or older
Exclusion Criteria:
Co-existing terminal illness likely to be fatal within the next 12 months
End-stage HF (defined as American College of Cardiology Stage D HF)
Cognitive impairment that precludes the ability to give informed consent
Active suicidality (defined choosing option 1, 2 or 3 on Item 9 of the PHQ-9)
History of the death of a spouse or child within the past month
History of psychotic illness or bipolar illness
Current alcohol dependence or other substance abuse
Non-English speaking or possessing any other communication barrier
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Lexington Kentucky, 40536, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.